What is Uptravi 800 mcg, film-coated tablets used for?

( ARTG ) UPTRAVI is indicated for the treatment of:,- idiopathic pulmonary arterial hypertension;,- heritable pulmonary arterial hypertension;,- pulmonary arterial hypertension associated with connective tissue disease;,-pulmonary arterial hypertension associated with congenital heart disease with repaired shunts;,-pulmonary arterial hypertension associated with drugs and toxins;,in patients with WHO functional class II, III or IV symptoms

What are the side effects of Uptravi 800 mcg, film-coated tablets?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can Uptravi 800 mcg, film-coated tablets be used during pregnancy?

( AHT ) For the active ingredient selexipag You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

What ATC class does Uptravi 800 mcg, film-coated tablets belong to?

Uptravi 800 mcg, film-coated tablets: ATC B01AC27. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Uptravi 800 mcg, film-coated tablets

Data updated: 2026-04-11

Available in:

🇨🇿🇩🇪🇬🇧🇸🇰

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

Janssen-Cilag AG

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.